Standout Papers

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading t... 2015 2026 2018 2022 394
  1. EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291 (2015)
    Kenneth S. Thress, Roz Brant et al. Lung Cancer

Immediate Impact

5 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
2024 Standout
6 intermediate papers

Works of T. Hedley Carr being referenced

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
2019
Defining actionable mutations for oncology therapeutic development
2016
and 2 more

Author Peers

Author Last Decade Papers Cites
T. Hedley Carr 591 339 496 420 19 937
Kyle Furge 284 640 365 224 20 1.0k
Yacine Barèche 346 310 207 598 25 996
Sabine Hellwig 502 447 170 234 18 777
Frank Gebhardt 201 647 318 397 20 1.1k
Zhongzhong Ji 295 620 232 297 27 977
Laura Castellini 309 431 149 348 19 1000
Pengchin Chen 218 633 187 227 15 1.1k
Zhi L. Teo 269 404 210 696 18 1.1k
Aurore Rampanou 532 288 265 438 17 833
Qing Hao Miow 322 522 156 452 14 964

All Works

Loading papers...

Rankless by CCL
2026